Jump Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $730K | Sell |
43,577
-1,281,949
| -97% | -$21.5M | 0.01% | 1079 |
|
|
2025
Q1 | $20.4M | Buy |
1,325,526
+838,423
| +172% | +$12.9M | 0.28% | 87 |
|
|
2024
Q4 | $10.7M | Buy |
487,103
+273,493
| +128% | +$6.03M | 0.22% | 101 |
|
|
2024
Q3 | $3.85M | Buy |
213,610
+181,110
| +557% | +$3.26M | 0.08% | 293 |
|
|
2024
Q2 | $528K | Sell |
32,500
-484,511
| -94% | -$7.87M | 0.01% | 1108 |
|
|
2024
Q1 | $7.3M | Buy |
517,011
+476,011
| +1,161% | +$6.72M | 0.2% | 74 |
|
|
2023
Q4 | $428K | Sell |
41,000
-177,799
| -81% | -$1.86M | 0.01% | 1157 |
|
|
2023
Q3 | $2.23M | Sell |
218,799
-229,821
| -51% | -$2.34M | 0.08% | 329 |
|
|
2023
Q2 | $3.38M | Buy |
448,620
+344,507
| +331% | +$2.59M | 0.12% | 208 |
|
|
2023
Q1 | $921K | Buy |
+104,113
| New | +$921K | 0.04% | 630 |
|
|
2022
Q3 | – | Sell |
-676,044
| Closed | -$5.08M | – | 1959 |
|
|
2022
Q2 | $5.08M | Buy |
676,044
+343,007
| +103% | +$2.58M | 0.22% | 82 |
|
|
2022
Q1 | $3.13M | Buy |
333,037
+311,637
| +1,456% | +$2.93M | 0.13% | 185 |
|
|
2021
Q4 | $171K | Sell |
21,400
-191,496
| -90% | -$1.53M | 0.01% | 1145 |
|
|
2021
Q3 | $2.07M | Buy |
212,896
+200,280
| +1,588% | +$1.95M | 0.15% | 140 |
|
|
2021
Q2 | $125K | Buy |
+12,616
| New | +$125K | 0.01% | 954 |
|